Ucb Biopharma Srl

This study tested a new drug called bimekizumab in 49 adults with moderate to severe plaque psoriasis. The goal was to see how well it cleared skin symptoms and how safe it was over 28 weeks. Results showed significant improvement in psoriasis severity, with the drug being genera…

This study tested a drug called rozanolixizumab in 200 adults with generalized myasthenia gravis, a condition causing muscle weakness. The goal was to see if the drug improves daily activities and is safe compared to a placebo. Results showed it may help reduce symptoms like trou…

This study looked at whether 62 adults with generalized myasthenia gravis could safely give themselves the drug rozanolixizumab at home after training. Participants used either a syringe driver or manual push method. The main goal was to see if they could correctly choose the inj…

This study tested whether adding brivaracetam to existing epilepsy medications helps reduce partial seizures in adults aged 16 to 80. Over 400 participants took either the drug or a placebo for 12 weeks. The main goals were to check safety and see if seizure frequency dropped. Re…

This study tested a new medicine, bimekizumab, for people with active psoriatic arthritis, a condition causing joint pain and swelling. About 852 adults took part, comparing bimekizumab to a placebo and an existing drug (adalimumab). The main goal was to see if bimekizumab could …

This study tested a new medicine called UCB1381 in healthy volunteers and people with moderate to severe atopic dermatitis (eczema). The goal was to check if the drug is safe and if it can improve skin symptoms like redness and itching. Researchers measured side effects and used …

This study tested a new medicine called UCB9741 in healthy volunteers and people with moderate-to-severe atopic dermatitis (eczema). The main goals were to check if the drug is safe and how the body processes it. Researchers also looked for early signs that it might improve eczem…

This study looked at whether people with generalized myasthenia gravis could safely switch from an IV infusion to a daily shot of zilucoplan. 26 adults who were stable on IV treatment took part. The main goal was to check for side effects and see if the switch kept their symptoms…

This study looked at the long-term safety and tolerability of the drug brivaracetam in 84 children and young adults (ages 2 to 26) with childhood or juvenile absence epilepsy. Absence epilepsy causes brief staring spells. The main goal was to see how many participants had side ef…

This study tested how quickly an inhaled form of alprazolam (Staccato) starts working compared to two other sedatives given by IV or nasal spray. Fifty-five healthy adults received single doses of each drug on different days while their brain activity was monitored with an EEG. T…

This study looked at how much of the drug rozanolixizumab passes into breast milk after a single dose. Fifteen healthy, lactating women who had already decided to stop breastfeeding took part. Researchers collected breast milk samples over 7 days to measure drug levels and estima…

This study looked at whether giving the drug zilucoplan by a prefilled syringe or an auto-injector leads to similar levels in the blood. It involved 14 healthy adults and was already completed. The goal was to check safety and how the body processes the drug, not to treat any dis…

This was an early-stage study to check the safety and see how the body processes a new drug called UCB9741. It involved 40 healthy adult volunteers from Caucasian and Japanese backgrounds who received a single injection. The main goal was to monitor for any side effects and measu…